Condition
Positron Emission Tomography clinical trials and research
As of November 12, 2026, Find a Trial lists 21 Positron Emission Tomography clinical trials that are recruiting, at sites in 7 countries (most in China (13), Belgium (2), United Kingdom (2)). By phase: Early Phase 1 (5), Phase 2/3 (1). The most active sponsors are Tianjin Medical University (6), First Affiliated Hospital of Chongqing Medical University (2), The First Affiliated Hospital of Xiamen University (2). There are also 17 NIH-funded research projects on Positron Emission Tomography, with $7.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 21Clinical trials
- 17NIH research projects
- 7Countries
Newest Positron Emission Tomography clinical trials
All recruiting trials (21)
-
PD-L1 PET/CT to see primary and metastatic PD-L1-related lesions in adults
This study tests whether 68Ga/18F-PD-L1 PET/CT can help detect primary and metastatic PD-L1-related tumors in adults.
-
FAPI-PET/CT imaging for diagnosing and staging pancreatic cancer
This study will try 18F‑FAPI‑74 PET/CT scans in adults with suspected or recurrent pancreatic cancer to see if they detect lymph node spread and distant metastases more accurately.
-
Establishing a cohort for Alzheimer's disease research in China
This study is trying to understand how brain scans and other health markers relate to Alzheimer's disease in both people with and without cognitive issues in China, to help find ways to detect and prevent the disease early.
-
Using PET/CT imaging to diagnose GLP-1 receptor related diseases
This study is testing a special imaging scan to see if it can help doctors better diagnose cancer in adults who may have diseases related to GLP-1 receptors.
-
Evaluating PSMA PET/CT Imaging for Prostate Cancer Patients
This study is testing a special type of imaging called PSMA PET/CT to see if it can help find cancer in adults who have or might have prostate cancer.
-
Evaluating PET/CT for SSTR-related diseases
This study is testing a new type of PET/CT scan to see if it can help find cancer spots in adults who have tumors related to SSTR diseases.
-
Imaging CXCR4-related diseases using PET/CT
This study is testing a new type of imaging to see if it can better identify and track diseases related to CXCR4 in patients.
-
Evaluating FAPI PET/CT for Diagnosing FAP-Related Diseases
This study is testing if a special type of scan can help find cancer in adults who have or might have tumors related to FAP.
-
New PET tracer ([11C]CHDI-00491009) to image mutant huntingtin in Huntington disease
This project will test a new PET tracer ([11C]CHDI-00491009) to see if it binds mutant huntingtin aggregates in adults with Huntington disease and in healthy volunteers.
-
PET imaging of brain and liver inflammation in fatty liver disease
This research will test whether PET scans using 18F-FDG and 18F-DPA-714 can see inflammation in both the liver and brain of adults with fatty liver disease who have recent or planned liver biopsies.
-
PET imaging of STING expression in cancer patients
This study is testing a new imaging agent to see if it can safely help doctors visualize a specific protein in tumors of adults with cancer, which may improve cancer treatment.
-
Imaging with 68Ga-PSFA in patients with specific cancer markers
This study is testing a new imaging agent to see if it can help find cancer spots in patients with certain cancer markers.
-
Investigating imaging techniques for diagnosing non-convulsive status epilepticus
This study is testing three different imaging techniques to see which one best helps doctors diagnose non-convulsive status epilepticus in patients.
-
Imaging with a new PET agent for SSTR2 positive diseases
This study is testing a new imaging agent to see if it can provide better results for patients with SSTR2 positive diseases compared to the current standard imaging method.
-
Gene expression profiles in spinal tuberculosis
This study is trying to see if different gene patterns in spinal tuberculosis can help doctors better understand and treat the disease, especially in people with HIV.
-
Understanding serotonin release in Parkinson's disease
This study is trying to find a way to see changes in the brain of people with Parkinson's disease to help develop new treatments that could slow down the symptoms.
-
Investigating biomarkers for Parkinson's disease using advanced imaging techniques
This study is trying to find a marker for Parkinson's disease by using advanced brain scans to see how the disease affects brain chemistry and structure over time.
-
Using 68Ga-Pentixafor PET/CT to improve diagnosis and treatment of primary aldosteronism
This study is testing a new imaging method to see if it can help doctors better diagnose and treat people with primary aldosteronism, a condition that causes high blood pressure.
-
Stereotactic body radiotherapy for hormone-sensitive prostate cancer with few metastases
This study is testing whether a special type of targeted radiation therapy combined with standard treatment can help men with hormone-sensitive prostate cancer that has spread to a few places live longer and feel better.
-
68Ga-FAPI PET/CT imaging to detect primary and metastatic cancer lesions
This study tests whether 68Ga-DOTA/NOTA-FAPI-04 PET/CT can help find primary tumors and metastases in adults with various cancers.
-
Comparing two types of PET scans for cancer diagnosis
This study is testing whether a new type of PET scan can find cancer better than the standard scan in patients who have or might have tumors.
NIH-funded research (17)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A new PET tracer to help diagnose and stage 4R tau-related brain diseases
A new PET tracer is being tested to help doctors distinguish and stage diseases caused by the 4R form of tau protein in the brain.
-
Dopamine imbalances in OCD and tic disorders explored with brain imaging
A patient-focused look at how dopamine signaling in specific brain areas relates to OCD and tic disorders using PET imaging.
-
PET scans to measure a brain protein (SV2A) in essential tremor
This project uses PET brain scans to look for changes in the SV2A protein in people with essential tremor to help diagnose and follow the condition over time.
-
Using PSMA PET-CT scans to improve monitoring during active surveillance for prostate cancer
This project checks whether adding PSMA PET-CT scans helps find aggressive prostate cancer earlier in men who are being closely watched instead of treated.
-
Understanding how rTMS may reduce brain inflammation in depression and related brain conditions
This study tests whether a noninvasive brain stimulation (rTMS) changes brain inflammation in people with depression and certain brain conditions.
-
PET imaging of alpha-1 receptors in the brain for PTSD
A new PET brain scan to visualize alpha-1 adrenoceptors in people with PTSD to help identify who may benefit from prazosin treatment.
-
Understanding dopamine receptor changes in OCD and tic disorders
This study is looking at how certain brain receptors related to dopamine work differently in people with obsessive-compulsive disorder and tic disorders like Tourette syndrome, using special imaging to help find better ways to treat these conditions.
-
Measuring brain proteins to understand essential tremor
This study is looking at how a special brain protein can help doctors better understand and track essential tremor, so they can improve diagnosis and treatment for people living with this condition.
-
Improving the sensitivity of positron emission tomography imaging systems
This study is working on making PET scans better by using new technology to help doctors see clearer images, which could lead to more accurate diagnoses and better treatment plans for patients.
-
Evaluating a new imaging technique for monitoring prostate cancer in men on active surveillance
This study is looking at how a special imaging test called PSMA PET-CT can help doctors better monitor prostate cancer in men who are being watched closely instead of treated right away, with the goal of reducing unnecessary treatments and side effects for those with low-risk cancer.
-
Using advanced imaging to study multiple aspects of Alzheimer's disease
This study is exploring a new imaging method that uses multiple tracers to get a clearer picture of Alzheimer's disease, helping researchers understand how it progresses and find better ways to diagnose and treat it, all while making sure the imaging is safe and non-invasive for patients.
-
Creating a new imaging tool to visualize brain receptors related to PTSD
This study is testing a new imaging tool that helps doctors see specific brain receptors linked to PTSD, which could lead to better treatment options for people with this condition.
-
Developing advanced detector modules for improved PET imaging
This study is working on making PET scans better and more affordable by using a new type of material that helps capture images more clearly, which could help doctors diagnose and monitor your health more effectively.
-
New methods for faster and more accurate brain and heart imaging
This study is working on a new way to make PET scans faster and clearer, which could help doctors better diagnose and monitor heart and cancer conditions while using less radiation for patients.
-
Improving PET imaging using a new method with bismuth germanate
This study is exploring a new way to make PET scans clearer and more accurate by using a special material called bismuth germanate, which helps improve the timing of the images, making it easier for doctors to diagnose and plan treatments for different health issues.
-
Developing advanced materials to improve cancer imaging with PET scans
This study is testing a new technology that could make PET scans better for spotting cancer and heart disease, helping doctors see important details more clearly so they can provide more accurate diagnoses and treatment plans for patients.
-
Measuring brain glucose metabolism with a portable PET camera.
This study is testing a new portable brain scanner that can measure how your brain uses sugar without needing any needles, making it easier for people with mental health or brain conditions to get checked more often and in different places.
Related topics
Quick answers
How many Positron Emission Tomography clinical trials are recruiting right now?
21, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in China (13 trials), Belgium (2 trials), United Kingdom (2 trials), Sweden (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 5, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.